Low, Daniel
University of California, Los Angeles,
United States
2024 Rank: 42087
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 159 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42087 | 45219 |
| Total Cites | 1090 | 1182 |
| H-index | 12 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 61 | 61 |
| Total Cites to Single+First Authored Papers | 224 | 232 |
| Number of Single+First+Last Authored Papers | 247 | 247 |
| Total Cites to Single+First+Last Authored Papers | 474 | 497 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 807 | 847 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.40 |
| Self-Citation Percentage |
7.78%
|
|
Low, Daniel
David Geffen School of Medicine at UCLA,
United States
2023 Rank: 37809
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 143 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37809 | 42491 |
| Total Cites | 1094 | 1157 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 59 | 59 |
| Total Cites to Single+First Authored Papers | 252 | 252 |
| Number of Single+First+Last Authored Papers | 243 | 243 |
| Total Cites to Single+First+Last Authored Papers | 490 | 503 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 825 | 857 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.35 |
| Self-Citation Percentage |
5.45%
|
|
Low, Daniel
University of California, Los Angeles,
United States
2021 Rank: 34861
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 126 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 34861 | 37141 |
| Total Cites | 1598 | 1785 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 58 | 58 |
| Total Cites to Single+First Authored Papers | 409 | 426 |
| Number of Single+First+Last Authored Papers | 241 | 241 |
| Total Cites to Single+First+Last Authored Papers | 721 | 768 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1201 | 1271 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.40 |
| Self-Citation Percentage |
10.48%
|
|
Low, Daniel
David Geffen School of Medicine at UCLA,
United States
2020 Rank: 29639
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 113 out of 84246 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29639 | 27268 |
| Total Cites | 1255 | 1426 |
| H-index | 12 | 14 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 370 | 383 |
| Number of Single+First+Last Authored Papers | 238 | 238 |
| Total Cites to Single+First+Last Authored Papers | 568 | 605 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 953 | 1018 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.40 |
| Self-Citation Percentage |
11.99%
|
|